Barone Francesca 4
4 · Candel Therapeutics, Inc. · Filed Jul 1, 2026
Research Summary
AI-generated summary of this filing
Candel (CADL) CSO Francesca Barone Sells 23,447 Shares
What Happened
Francesca Barone, Chief Scientific Officer of Candel Therapeutics (CADL), sold 23,447 shares on 2026-06-29. The reported weighted-average price was $10.06 per share, generating proceeds of about $235,769. The sale was effected pursuant to a 10b5-1 trading plan, which typically indicates a pre-arranged, automated sale rather than discretionary insider timing.
Key Details
- Transaction date: 2026-06-29 (reported on Form 4 filed 2026-07-01) — filing appears timely.
- Transaction type/code: Sale (S) — open market or private sale.
- Shares sold: 23,447; reported weighted-average price: $10.06; total proceeds: ~$235,769.
- Price range: shares were sold in multiple trades at prices between $10.00 and $10.14; the filing reports a weighted average and the filer can provide a breakdown on request (per footnote).
- Shares owned after transaction: Not disclosed in this filing.
- Notable footnotes: Transaction executed under a 10b5-1 plan adopted 2026-03-16 (pre-arranged plan).
Context
Because the sale was part of a 10b5-1 plan, it was pre-scheduled and is generally viewed as routine rather than a direct signal of the officer’s view on the company's near-term prospects. Sales are common for liquidity or diversification reasons; purchases are typically more informative about insider sentiment.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-06-29$10.06/sh−23,447$235,769→ 77,362 total
Footnotes (2)
- [F1]This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 3/16/2026.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 herein.